ReviewGynecology and minimally invasive therapy
Hysteroscopy and Retained Products of Conception: An Update.
Review in Gynecology and minimally invasive therapy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07206342 (Evaluation of the Non-inferiority of Resorbable Gelatin Embolization Compared to Embolization Combined With Endometrial Aspiration for the Management of Hemorrhagic Uterine Vascular Abnormalities Following Premature Termination of Pregnancy), which is not on this map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of the Non-inferiority of Resorbable Gelatin Embolization Compared to Embolization Combined With Endometrial Aspiration for the Management of Hemorrhagic Uterine Vascular Abnormalities Following Premature Termination of Pregnancy
Who cites it
30 citing papers in PubMed.
- Managing uterine evacuation in a patient with Asherman syndrome who failed procedural and medication abortions: a case report.Case reports in women's health · 2026Article
- Sonography-Assisted Management of Suspected Retained Products of Conception Upon Completion of the Puerperium: A Prospective Single-Center Study.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2026Article
- Article
- An Unusual Case of Rising Serum βhCG in the Setting of Retained Products of Conception: A Case Report.Cureus · 2026Article
- Development and Validation of an Interpretable Machine Learning Model for Prediction of the Need for Surgical Evacuation in Patients with Incomplete Abortion.Risk management and healthcare policy · 2026Article
- Immediate initiation of oral contraceptive pills after an early pregnancy loss does not increase the risk of retained products of conception.Frontiers in reproductive health · 2026Article
- Pregnancy outcomes of patients with retained products of conception following miscarriage treated with relugolix, an oral gonadotropin-releasing hormone antagonist.Frontiers in medicine · 2026Article
- Management of uterine leiomyoma and adenomyosis: role of hysteroscopy in diagnosis and norethindrone in the treatment.Scientific reports · 2025Article
- The paradox of early pregnancy care: Overtreatment amid systemic neglect.Acta obstetricia et gynecologica Scandinavica · 2025Article
- Ultrasound Assessment of Retained Products of Conception (RPOC): Insights from the Current Literature.Journal of clinical medicine · 2025Review
- Embolization with gelatin foam in the management of vascularized retained products of conception: a multicenter study by the French Society of Cardiovascular Imaging.European radiology · 2025Article
- Sonographic evaluation of retained products of conception within 48 h following delivery: a retrospective cohort study.Archives of gynecology and obstetrics · 2025Article
- Pseudo-myometrial thinning in placental site trophoblastic tumors: a case series with multiparametric MRI.Abdominal radiology (New York) · 2025Article
- The effectiveness of an oral gonadotropin-releasing hormone antagonist relugolix for retained products of conception (RPOC) formed after abortion at less than 22 weeks of gestation: a retrospective study.Frontiers in medicine · 2025Article
- The application value of 5 Fr non-contact hysteroscopy in the diagnosis and treatment of intrauterine diseases in perimenopausal and postmenopausal women.BMC surgery · 2024Article
- Primary and secondary postpartum haemorrhage: a review for a rationale endovascular approach.CVIR endovascular · 2024Review
- Article
- Hysteroscopy-assisted suction curettage for early pregnancy loss: does it reduce retained products of conception and postoperative intrauterine adhesions?Archives of gynecology and obstetrics · 2024Article
- Operative hysteroscopy versus ultrasound-guided electric vacuum aspiration for removal of retained products of conception: A prospective cohort study.European journal of obstetrics & gynecology and reproductive biology: X · 2023Article
- Ultrasound for diagnosis of postpartum retained products of conception-How accurate we are?BMC pregnancy and childbirth · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retained products of conception (RPOC) can occur after early or mid-trimester pregnancy termination and also following vaginal or cesarean delivery. It is frequently associated with continuous vaginal bleeding, pelvic pain, and infection. Late complications include intrauterine adhesions formation and infertility. Conventionally, the management of RPOC has been with blind dilation and suction curettage (D and C); however, hysteroscopic resection of RPOC is a safe and efficient alternative. In this review, we analyze the current available evidence regarding the use of hysteroscopic surgery for the treatment of RPOC comparing outcomes and complications of both traditional curettage and hysteroscopic technique. Data search has been conducted using the following databases MEDLINE, EMBASE, Web of Sciences, Scopus, Clinical Trial. Gov., OVID, and Cochrane Library interrogate all articles related to hysteroscopy and the preserved product of conception, updated through September 2020.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.